http://orcid.org/0000-0001-9469-3618
Figures
Abstract
Background
Ivermectin is the only drug currently recommended for the treatment of onchocerciasis, the second leading infectious cause of blindness in the world. This drug kills only the first stage larvae—microfilariae (mf) of Onchocerca volvulus and is to be used cautiously in areas where Loa loa is prevalent because of severe adverse events observed with coinfected patients.
Methodology/Principal findings
This study investigated the anti-filarial activities of two Cameroonian medicinal plants, Lantana camara and Tamarindus indica locally used to treat onchocerciasis. Twelve (12) extracts were prepared and tested in vitro on the bovine model parasite, O. ochengi as well as L. loa mf. Both mf and adult male worm viabilities were assessed by motility scoring, while adult female worm viability was determined biochemically by standard MTT/formazan colorimetry. Cytotoxicity and acute toxicity were determined respectively, in monkey kidney epithelial cells and in BALB/c mice. Pure compounds were isolated by LC/MS using a bio-assay guided strategy. All the extracts showed 100% activity at 500 μg/mL against O. ochengi adult worms and mf. The highest activity against O. ochengi was observed with the hexane extract of L. camara leaves (LCLhex), with IC50 of 35.1 μg/mL for adult females and 3.8 μg/mL for the mf. Interestingly, this extract was more active against O. ochengi mf than L. loa mf. Further studies on the extracts led to the isolation of lantadene A from the methylene chloride extract of L. camara leaves, with IC50s of 7.85 μg/mL for adult males, 10.38 μg/mL for adult females, 10.84 μg/mL for O. ochengi mf and 20.13 μg/mL for L. loa mf.
Author summary
Onchocerciasis is a chronic disease of humans that affects mainly the skin and eyes. It is an insect-borne disease, caused by a nematode worm, Onchocerca volvulus. It is a public health problem and an obstacle to socio-economic development in affected communities. There is currently no vaccine, and no adult worm drug to cure the infection. The only recommended drug, ivermectin can give short-term relief by killing the microfilariae of the parasite but cannot always be safely administered in mass drug administration (MDA) in areas where another filarial worm, Loa loa is co-endemic. To prevent infection and completely eradicate the disease there is an urgent need for alternative drugs that can kill the adult worms but to a lesser extent Loa loa. In the past, medicinal plants have served as good starting points for the development of drugs. In the present study, we determined the filaricidal properties of extracts, chromatographic fractions of Lantana camara and Tamarindus indica and lantadene A against Onchocerca ochengi, the bovine model of the parasite and L. loa. Interestingly, most of the active extracts were more active against O. ochengi than on L. loa mf. No death was recorded following oral administration of the active extracts to BALB/c mice. Lantadene A is a potential lead molecule for the development of a cure for onchocerciasis.
Citation: Ngwewondo A, Wang M, Manfo FPT, Samje M, Ganin’s JN, Ndi E, et al. (2018) Filaricidal properties of Lantana camara and Tamarindus indica extracts, and Lantadene A from L. camara against Onchocerca ochengi and Loa loa. PLoS Negl Trop Dis 12(6): e0006565. https://doi.org/10.1371/journal.pntd.0006565
Editor: Uwem Friday Ekpo, Federal University of Agriculture, NIGERIA
Received: December 15, 2017; Accepted: May 26, 2018; Published: June 13, 2018
Copyright: © 2018 Ngwewondo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its supporting information files.
Funding: The authors received funding from the World Health Organisation/ Tropical Disease Research granted to FCN and from the Natural Sciences and Engineering research council of Canada provided by a grant to RJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Onchocerciasis (river blindness) is a blinding and debilitating disease caused by the parasitic nematode, Onchocerca volvulus. According to estimates of the World Health Organization (WHO) [1], 37 million people are infected, 800,000 visually impaired and 270,000 blinded. Adult worms of O. volvulus can live for up to 15 years in subcutaneous nodules (onchocercoma) and produce millions of microfilariae (mf) which parasitize skin and eye tissues, resulting in major pathologies such as intense and often unbearable itching, disfiguring dermatitis, atrophy, visual impairment and blindness [2]. The microfilaricide, ivermectin was shown to be safe and effective in the treatment of onchocerciasis and is currently the only recommended drug for control of the disease by a mass drug administration (MDA) strategy [3]. The emergence of animal parasite strains resistant to ivermectin and an abundance of reports of resistance or low response rates of O. volvulus mf to the drug are worrisome. Additionally, the use of ivermectin in MDA in areas of high Loa loa co-endemicity is limited due to severe adverse events (including encephalopathy and death) observed with some coinfected patients [4]. Since ivermectin is only effective against the mf, prolonged annual therapy for at least 10 to 15 years is required to interrupt transmission and clear onchocerciasis from a human population [5]. Therefore, there is the need for a safe and more effective macrofilaricidal drug for the cure of onchocerciasis or an alternative microfilaricide, preferably one that does not kill L. loa mf. Since onchocerciasis is a neglected tropical disease, such a drug has been difficult to find with the conventional for-profit pharmaceutical company approach, requiring alternative strategies to aid its discovery and development.
One strategy employed has been the exploitation of medicinal plants and other natural materials as alternative medicines or for the identification of novel potential drug leads. It has been shown that medicinal plants play a very important role in the health care needs of rural populations in Africa because they are cheap and readily available locally [6,7]. The majority of drugs active against infectious agents are in fact derived from natural products [8], including ivermectin derived from Streptomyces avermitilis [9] and artemisinin from the medicinal plant, Artemisia annua [10]. Previous studies have revealed the filaricidal properties of several Cameroonian medicinal plants [11–13]. Tamarindus indica lotions and extracts are widely used by indigenes to treat conjunctivitis, dysentery, jaundice, hemorrhoids and onchocerciasis. Lantana camara contains principles active against Mycobacterium tuberculosis and has been used in the traditional treatment of onchocerciasis in parts of Cameroon [14]. This study thus sought to investigate the filaricidal properties of extracts from Lantana camara (Verbenaceae) and Tamarindus indica (Leguminosae) against cattle derived O. ochengi, the closest known relative of O. volvulus [15], and against L. loa mf, in order to assess their acclaimed activities and their possible use as sources of new drug leads for onchocerciasis.
Materials and methods
Ethics statement
Ethical clearance (No. 2013/11/371/L/CNERSH/SP) and administrative clearance (No. 631–06.14) for blood collection from L. loa infected humans were obtained from the Cameroon National Ethics Committee and the Ministry of Public Health, respectively. All subjects of age 20–55 granted written and informed consent before any blood for diagnosis or worm preparation was collected.
Plants and plant extracts
Both L. camara and T. indica were collected in January, 2013 based on ethno pharmacological information from Bafoussam and Oshei communities in the West and North West Regions of Cameroon, respectively. Voucher specimens were taken to the Yaoundé herbarium where they were authenticated by Mr. Onana Jean Marie and voucher numbers were assigned to them (L. camara: 25900 SRF CAM; T. indica: HNC/42429). The leaves, stem bark and roots of each plant were air dried and ground to fine powder using a grinding mill. Each powder was macerated for 48 hours, sequentially, in hexane, methylene chloride, and methanol. The filtrate was concentrated using a rotary evaporator (BUCHI Rotavapor R-200, Switzerland) and crude extracts weighed and preserved at -20°C for further use.
The percentage yield in extract was calculated using the following formula:
A stock solution of 25 mg/mL was prepared in >99.8% DMSO (Sigma, Germany) and kept at -20°C until tested in biological assays.
Isolation of O. ochengi adult worms
Worms were isolated from umbilical areas of infected cattle skin as previously described by Cho-Ngwa et al. [11]. Briefly, cattle skin containing palpable nodules obtained from the butchery in Douala Cameroon were washed with soap and rinsed with distilled water. The skin was then sterilized with 70% ethanol after which the nodules were carefully opened and the entire nodular content removed and submerged in 2 mL of complete culture medium (CCM) comprising of RPMI-1640 (SIGMA cat: R0883), supplemented with 25 mM HEPES, 2 g/L sodium bicarbonate, 2 mM L-glutamine, 5% heat inactivated new born calf serum (SIGMA Cat: N4762), 200 units/mL penicillin/ 200 μg/mL streptomycin and 0.25 μg/mL amphotericin B, pH 7.4 in 12-well culture plates. The worms were left in cultures in a HERACELL-CO2 incubator (Thermo Fisher, UK) overnight and checked for any contamination before drugs were added.
Mammalian cells for microfilarial cultures and cytotoxicity studies
Monkey kidney epithelial cells (LLC-MK2) obtained from the American Type Culture Collection (ATCC) were proliferated in 96-well microtitre plates in CCM medium at 37°C in 5% CO2 humidified air. At confluency, the cells served as feeder layers for the mf cultures.
Isolation and culturing of O. ochengi microfilariae
This was prepared as described by Bianco et al., [16] with slight modifications. Briefly, fresh pieces of umbilical cattle skin were obtained from the butchery and washed thoroughly. Few skin snips from different locations of the skin were obtained and incubated in small amounts of culture medium for 15 minutes, after which the emergent mf were qualified and quantified using an inverted microscope and standard atlases for reference [17]. The remainder of a selected piece of skin was shaved, rinsed and sterilized with 70% ethanol and sliced into thin slivers. The slivers were incubated in CCM for 2 hours, and the emergent highly motile O. ochengi mf were concentrated by centrifugation. The mf were transferred into 96 -well microtitre plates (15 mf /100 μL/ well) already containing fully confluent LLC-MK2 cell layer in 100 μL of CCM and monitored for viability and sterility for 24 hours before addition of test and control compounds.
Preparation of Loa loa microfilariae
Identification of L. loa mfs was done using standard atlases after staining with giemsa and observing the slide under the microscope [18]. Whole blood was collected in an EDTA tube from patients not receiving treatment and transported immediately to the Laboratory. The mf load was determined with the aid of an inverted microscope after diluting a portion of the blood in RPMI-1640 medium. After this the blood was diluted according to the number of mf present at initial count so as to obtain a total of 15 mf/100 μL/well. After dilution, the mf were distributed in 96-well plate and monitored for 24 hours before addition of test and control compounds.
Primary screens against O. ochengi adult worms
Extracts were tested at 500 μg/mL in triplicates in CCM. Auranofin at 10 μM, which had previously shown activity against O. ochengi adult worms and mf [19] was used as positive control, while negative control wells received the diluent, 2% DMSO only, previously shown to have no effect on parasite viability. The worm cultures with drug were incubated for 168 hours (7 days), at 37°C in 5% CO2 atmosphere. On the last day of incubation, the female worms were removed and incubated in 500 μL of 0.5 mg/mL MTT for 30 minutes. Inhibition of formazan formation from MTT directly correlates with worm death. The worms were blotted on absorbent paper and observed visually for blue coloration against a white background. Scores based on activity were assigned, ranging from 100% inhibition of formazan formationcompletely pale yellow worm, 90% inhibition; only one or few spots of blue color seen on worm, 75% inhibition; about 75% of worm remained pale yellow, 50% inhibition; about 50% of worm remained pale yellow, to 25% inhibition; near total blue coloration, to 0% inhibition; for total blue color on worm for inactive compound.
Adult male worm motility was evaluated using an inverted microscope. Scores were attributed to the worms using the following code: Vigorous or normal movement of whole worm, corresponding to 0% inhibition of worm motility; near normal movement of whole worm or 25% inhibition of worm motility; whole body of worm motile but sluggish i.e. 50% inhibition of worm motility; only head or tail of worm moving i.e. 75% inhibition of worm motility; completely immotile worm i.e. 100% inhibition of worm motility.
Secondary screens against O. ochengi adult worms
Extracts with 100% activity at primary screens were re-tested as described under primary screens and at serial dilutions of seven concentrations (from 500 to 7.8125 μg/mL), in order to determine the IC50 values. The IC50 assays were done in triplicates and each experiment repeated for confirmation. The means of all activities at a concentration were calculated and used in the statistical analyses. GraphPad prism version 6.0 (GraphPad Software, CA, USA) was used to generate dose response curves from which the IC50 values were obtained.
Primary screens against O. ochengi microfilariae
Assays were conducted at 500 μg/mL in duplicates in the 96-well microtitre plates. The positive control drug was amorcazine at 30 μM and negative control was the diluent (DMSO). The mf were incubated with drug for 120 hours in a total of 200 μL of medium. Mf viability was assessed by microscopy once every day and motility inhibition scores were recorded as: 100% (immotile), 75% (only head or tail shaking), 50% (sluggish), 25% (almost vigorous motility), 0% (vigorous motility as with negative control). The day 5 data were used in determining drug activity. Motility inhibition correlates to drug activity.
Secondary screens against O. ochengi microfilariae
Extracts showing 100% activity in the primary screens were re-tested as described under primary screens at 8 serial dilutions (from 500–3.9 μg/mL) to determine the IC50 values. All assays were repeated at least once. The selectivity index (SI) of each extract was calculated as the ratio of the IC50 of the extract on mammalian cell (termed CC50) to the IC50 on parasites.
Screens against Loa loa microfilariae
All the extracts were screened against L. loa mf and the IC50 values determined. This was done at serial dilutions of eight concentrations (500–3.9 μg/mL), and according to the protocol used to screen extracts against O. ochengi mf. All assays were repeated at least once for confirmation of results.
Statistical analysis
Data were analyzed using GraphPad prism 6. The statistical significance of differences in means between the effects of extracts at various concentrations on parasites were determined by one-way analysis of variance (ANOVA), followed by Newman-Keuls multiple comparison tests. A value of p < 0.05 was considered significant.
Bioassay guided fractionation
Active extracts were chromatographed on a Sephadex LH-20 column using 4:1 MeOH/CH2Cl2 as eluent to give fractions A-E which were screened in quadruplicates at 50 μg/mL on all the developmental stages of O. ochengi and on L. loa mf. Fractions C and D were combined and further fractionated on a silica gel column with a gradient from 100% hexane to 100% EtOAc to give sub-fractions A-J and screened at the same concentration. Fraction D was recrystallized twice in MeOH to obtain needle-shaped crystals. The crystals were identified as lantadene A by analysis of their NMR and MS data (Fig 1).
Lantadene A: Colorless crystal (4.0 mg); 1H NMR (600 MHz, CDCl3) δ 5.97 (m, 1H), 5.35 (m, 1H), 5.06 (m, 1H), 3.02 (dm, J = 13.9 Hz, 1H), 2.53 (m, 1H), 2.35 (dm, J = 14.2 Hz, 1H), 1.99 (m, 1H), 1.95 (dm,J = 6.5 Hz, 3H), 1.90 (m, 1H), 1.87 (dm, J = 13.5 Hz, 2H), 1.79 (br. d, J = 14.1 Hz, 2H), 1.74 (m, 1H), 1.73 (br. d, J = 5.6 Hz, 3H), 1.65 (m, 1H),1.49 (m, 1H), 1.46 (m, 2H), 1.39 (dm, J = 6.7 Hz, 2H), 1.28 (m, 1H), 1.27 (m, 2H), 1.26 (m, 2H), 1.15 (br. s, 3H), 1.07 (br. s, 3H), 1.03 (br. s, 3H), 1.02 (br. s, 3H), 0.98 (br. s, 3H), 0.87 (br. s, 3H), 0.80 (br. d, J = 5.7 Hz, 3H); 13C NMR(150 MHz, CDCl3) δ217.9, 179.7, 166.4, 143.3, 139.3, 127.8, 122.7, 76.0, 55.5, 50.8, 47.6, 47.1, 46.1, 42.2, 39.4, 39.3, 38.6, 37.9, 37.0, 34.3, 33.9, 32.4, 30.2, 27.8, 26.7, 26.3, 26.0, 24.4, 23.7, 21.7, 20.8, 19.7, 17.1, 15.9, 15.3; HRESIMS [M+Na]+m/z 575.3708 (calcd for C35H52O5Na, 575.3712).
Screening of lantadene A against the parasites
Lantadene A was first tested at 50 μg/mL in the primary screens against the males, females and mf of O. ochengi and L. loa mf. Thereafter, it was tested in secondary screens from 40 μg/mL—0.31 μg/mL for adult worms, 40 μg/mL—0.16 μg/mL for O. ochengi mf and 40 μg/mL– 10 μg/mL for Loa loa mf in order to determine its IC50 values, using the same assays described for the extracts.
Cytotoxicity studies
Cytotoxicity of extracts with anti-Onchocerca activities was assessed on LLC-MK2 cells, microscopically, on day 5 of the mf assay. Living cells were flattened out and attached to the culture plate, while dead cells were rounded up and detached from the plate. The IC50 values for these cells were estimated from the morphological deformation data.
Acute toxicity studies
This test was conducted in accordance with the OECD guideline for testing of chemicals [20] and the animal protocol IACUC No UBAP2014-001 was approved by the Animal Care and Use Committee of the Faculty of Science, University of Buea. The three most active extracts (LCLmc, TILmc and LCLhex) were tested for acute toxicity in BALB/c mice.
Thirty-two animals of approximately 21.67g body weight each were divided into 4 groups (each group consisting of 1 subgroup of 4 males and 1 subgroup of 4 females). Each of the 3 treatment groups received one of the extracts at a limit dose of 2000 mg/kg body weight, administered orally in a maximum volume of 280 μL of corn oil per animal; while the control group received the diluent only. The animals were observed for any changes in physical activity, food intake, water intake, stool sample, loss of fur, sensitivity to sound, sensitivity to pain, motility and mortality, every day for 14 days.
Phytochemical analyses
The phytochemical properties of the active extracts were determined using standard procedures: Mayer and freshly prepared Dragendoff’s reagents for alkaloïds, Liebermann-Buchard test for triterpenoids and sterols, FeCl3 and K3Fe[(CN)6] for phenols, Shinoda’s test for flavonoids, frothing test for saponins [21].
Results
The twelve (12) crude extracts obtained from the 2 plants, L. camara and T. indica, were first tested at 500 μg/mL in primary screens against O. ochengi worm stages. All of the extracts showed 100% activity against adult worms and mf. The extracts were further screened at various concentrations on adult worms and mf in order to determine their IC50s. The hexane and methylene chloride extracts of L. camara leaves (LCLhex and LCLmc, respectively) were the most active against adult male worms with IC50s of 7.3 and 7.8 μg/mL, and O. ochengi mf with IC50s of 3.8 and 3.9 μg/mL, respectively. Moreover, LCLhex and methylene chloride extract of T. indica leaves (TILmc) were the most active extracts against female worms with IC50s of 35.1 μg/mL and 62.5 μg/mL, respectively. Seven of the twelve extracts had lower activities (higher IC50s) against L. loa mf than O. ochengi mf (Table 1). LCLhex, LCLmc, and TILmc had IC50s of 62.5 μg/mL, 55.6 μg/mL and 64.5 μg/mL, for L. loa respectively. LCLhex and LCLmc had IC50 values for L.loa 16.4 and 14.3 times higher than that for O. ochengi mf, respectively (Fig 2).
(TILmc: methylene chloride extract from Tamarindus indica leaves; LCLhex: hexane extract from Lantana camara leaves; LCLmc: methylene chloride extract from Lantana camara leaves).
Comparing the mean activities of the different extracts tested against males, females and microfilariae of O. ochengi and L. loa, we observed a dose dependent effect from 500–3.90625 μg/mL. At a fixed extract concentration (250–7.8125 μg/mL) there were significant differences (p < 0.05) between the different types of extracts. For the same extract type at a fixed concentration there was a difference in the response of males, females and microfilariae of O. ochengi and L. loa (Table 2, 3, 4 and 5).
The drug concentrations inducing cytotoxicity in 50% of cells (CC50) were 46.4 μg/mL, 7.8 μg/mL and 7.8 μg/mL for TILmc, LCLhex and LCLmc, respectively. Thus, the selectivity index (SI) values of the extracts for adult worms and mf ranged from 0.12–2.07 (Table 6). In general, the cytotoxicity assay demonstrated that about 57% of the 12 extracts had SI values below 1, a clear indication of cytotoxic tendencies for the crude preparations.
LCLhex, TILmc and LCLmc were selected for acute toxicity studies in BALB/c mice at a limit dose of 2,000 mg/kg body weight. No sign of acute toxicity was noticed in BALB/c mice. The average weights of the mice increased from 21.67g pre-treatment to 26.67g post-treatment. No change was observed in the physical appearance of the animals throughout the 14-day study period.
Phytochemical screening revealed different classes of secondary metabolites present in the three most active extracts (Table 7).
Further fractionation of the active extracts, LCLhex, LCLmc and TILmc yielded sub-fractions that were each screened on O. ochengi mf and adults at 50 μg/mL. The 6 fractions from LCLhex were inactive against the adult worms and mf, while 5 fractions from TILmc showed moderate activity against adult male and female worms, although inactive against them. Five fractions were obtained from LCLmc and marked activity was observed with two of the fractions (C and D) at 50 μg/mL against adult worms and mf. Combining these two fractions and fractionating further, 11 sub-fractions were obtained. When tested at 50 μg/mL against the male, female and mf of O. ochengi, 6 sub-fractions [C+D (C, D, D2, F, G, H)] were very active, 2 sub-fractions [C+D (E, I)] moderately active, while the others [C+D (A, B, J)] were inactive. From the above active fractions, the sub-fraction C+D-D4 was obtained, which showed 100% activity at 50 μg/mL (Table 8).
Further analysis by liquid chromatography/mass spectrometry (LC/MS) and recrystallisation of combined fractions C+D-D4 enabled isolation of the major compound, lantadene A (Fig 1). This pure compound showed 100% activity against O. ochengi and L. loa mf at 50 μg/mL in the primary screens; and for the secondary screens, IC100 of 20 μg/mL for the adult worms and IC50s of as low as 7.85 μg/mL for the adult male worms; while the IC100 and IC50 for L. loa mf were 30 μg/mL and 20.13 μg/mL, respectively (Fig 3).
Dose dependent relationships of lantadene A to parasite viability: A) % inhibition of motility of O. ochengi male worms. B) % inhibition of formazan by O. ochengi females. C) % inhibition of motility of Loa loa microfilariae (mf). D) % inhibition of motility of O. ochengi mf.
Discussion
In this study, we investigated the in vitro filaricidal activities of extracts of L. camara and T. indica; carried out a bioassay guided fractionation for identification of new drug leads for onchocerciasis and then isolated and determined the filaricidal properties of lantadene A from L. camara for the first time. Dose-dependent activity relationships were observed with the twelve extracts with IC50s ranging from 385.2 down to 3.8 μg/mL (Table 1). This indicates high anti-onchocerca properties of the plant extracts. The anti-filarial properties of lantadene A, which completely killed the parasites at 20 μg/mL were deemed encouraging, necessitating further studies on the compound.
In the secondary screens, the L. camara hexane extract (LCLhex) and the methylene chloride extract (LCLmc) showed significant differences against male worms and O. ochengi mf when compared to all the extracts. For the adult female worms, significant differences were observed with LCLhex and TILmc as compared to the other extracts. These differences of a particular extract tested at a single concentration acting differently on the different parasites might be due to the differences in proteins being expressed at the different stages or species. Also the differences observed when testing different extracts on one parasite shows the difference in composition of the extracts. Overall, higher activities were observed with the non-polar extracts than with the polar ones, corroborating previous findings that showed non-polar compounds, including essential oils to be nematicidal [22,23]. It is therefore suggested that, traditional healers find a way of reducing the polarity of their usual aqueous solvents in preparing the corresponding herbal medicines. But this must be confirmed in any clinical trials. The reduction in polarity could be by way of addition of suitable edible oils to the extracting media.
After confirming the filaricidal activity of the extracts, it was deemed necessary to investigate and obtain preliminary data on their safety. About 57% of the extracts tested were more toxic to the monkey kidney epithelial cells than to the worms as reflected in their SI < 1, probably due to complexity of the extracts, although none of the mice died after administration of the selected extracts at limit dose. These results underscore the importance of carrying out full toxicity and dosage studies on traditional medicines, which may generate new problems after the patient might have been cured of the original problem.
Serious adverse events (SAE) associated with incidental killing of L. loa mf in blood during treatment of patients coinfected with O. volvulus and L. loa have been reported [24], suggesting a need for drugs that will selectively kill O. volvulus without affecting or only moderately affecting L. loa mf. Interestingly, the most active extracts against O. ochengi adult males and mf (LCLhex and LCLmc) were less active for L. loa mf (Fig 2). This indicates that these extracts could be potential sources of such selective anti-Onchocerca drugs.
To identify novel leads for the development of new drugs for onchocerciasis, bio-assay guided fractionations of the extracts were carried out. Fractions from LCLhex and TILmc each showed no activity and moderate activity against the parasites respectively, although the whole extract itself was highly active. This implies that active principles from these extracts may be unstable, unable to withstand the fractionation process; or may be acting in synergy to provide the anti-parasitic activity, or even might have been over retarded in the column or missed out in the chromatographic process. Two fractions (C+D) from LCLmc showed marked activity against all the developmental stages of O. ochengi and L. loa mf when tested at 50 μg/mL. These yielded the compound lantadene A. The compound had previously been isolated from L. camara [25]. It is a pentacyclic triperpenoid, with molecular weight 552.78, is only sparingly soluble in water and crystallizes in methanol. It was shown to be active against tumors, Leishmania and soil nematodes [26,27]. At least 12 triterpenoids have been isolated and reported from L. camara, with some of their analogues being less toxic on cells and others having CC50s which go as low as <1 μM [26]. Like most or all drugs, lantadene A is toxic at higher doses, especially to livestock. Liver injury occurred after sheep were injected intravenously with lantadene A. A single dose of 1–3 mg/kg of the compound caused mild hepatocellular injury in sheep. Higher doses resulted in hepatic necrosis. It did not require metabolism in the alimentary tract for toxicity in sheep [25]. Reports of human toxicity by L. camara are rare. Most children with exploratory exposures to the plant remain asymptomatic. In the minority who develop mild effects, gastrointestinal irritation was most common. It is not known what substance produces these mild toxic effects in humans, but it does not appear that lantadene A or phototoxins contained therein are responsible [23]. Additional studies will therefore be needed to further investigate the anti-filarial effects of the other numerous compounds reported to be present in the plant by exploiting the structure–activity relationships to design better analogues that could be more active and non-toxic lead compounds for onchocerciasis treatment. The apparent low level of toxicity of lantadene A to humans could be supported by the current use of L. camara in traditional medicine of the present study population.
The IC50s of 7.85 μg/mL for adult males, 10.38 μg/mL for adult females and 10 μg/mL for monkey kidney epithelial cells obtained for lantadene A were deemed encouraging suggesting that it could be a potential lead for the development of an onchocerciasis cure. Also the IC50 of 20.13 μg/mL of lantedene A for L. loa mf as compared to the IC50 of 10.84 μg/mL for O. ochengi mf is an indication that lantadene A is less active against L. loa and so could be somewhat safe to administer in areas of Loa loa co-endemicity. Further bioassay-guided fractional studies on the extracts are also recommended as we believe that we have not yet isolated all the main anti-Onchocerca principles from them. This study has thus, reported for the first time the anti-filarial activity of these medicinal plants and of lantadene A.
Acknowledgments
The authors would like to thank the herbalists, Mr Nestor Nyambi Ombaku of Presbyterian Church, Ekeh, Oshie in NW Cameroon; and Mr Namegne of Casa, Bafoussam, West Region, Cameroon, for providing the ethno-pharmacological information needed for the plants investigated. Also Mr. Smith Babianka and Mr.Gamua Stanley of the Department of Chemistry and the Biotechnology Unit, respectively, of the University of Buea are thanked for their Laboratory assistance.
References
- 1.
WHO (2006–2011) Global Initiative for the Elimination of Avoidable Blindness. 29: 29.
- 2. Brattig N (2004) Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria. Microbes and Infection 6: 113–128. pmid:14738900
- 3. Whitworth J, Morgan D, Gilbert C, Mabey D, Maude G, et al. (1991) Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone. The Lancet 338: 1100–1103.
- 4. Turner JD, Tendongfor N, Esum M, Johnston KL, Langley RS, et al. (2010) Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial. PLoS Negl Trop Dis 4: e660. pmid:20405054
- 5. Richards FO, Miri E, Meredith S, Guderian R, Sauerbrey M, et al. (1998) Onchocerciasis. Bulletin of the World Health Organization 76: 147. pmid:10063699
- 6. Comley J (1990) New macrofilaricidal leads from plants? Tropical medicine and parasitology: official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ) 41: 1–9.
- 7. Ebigwai J, Ilondu E, Markson A, Ekeleme E (2012) In vitro evaluation of the essential oil extract of six plant species and ivermectin on the microfilaria larva of Simulium yahense. Res J Med Plant 6: 461–465.
- 8.
Kokate C GS (1994) Practical pharmacocognosy. In: P NP, editor. 2nd ed. pp. 54–60.
- 9. Lindley D (1987) Merck's new drug free to WHO for river blindness programme. Nature 329: 752.
- 10. Phillipson (2000) Phytochemistry and medicinal plants. Phytochem 56: 237–243.
- 11. Cho-Ngwa F, Abongwa M, Ngemenya MN, Nyongbela KD (2010) Selective activity of extracts of Margaritaria discoidea and Homalium africanum on Onchocerca ochengi. BMC complementary and alternative medicine 10: 62. pmid:21029456
- 12. Metuge JA, Nyongbela KD, Mbah JA, Samje M, Fotso G, et al. (2014) Anti-Onchocerca activity and phytochemical analysis of an essential oil from Cyperus articulatus L. BMC complementary and alternative medicine 14: 1.
- 13. Samje M, Metuge J, Mbah J, Nguesson B, Cho-Ngwa F (2014) In vitro anti-Onchocerca ochengi activities of extracts and chromatographic fractions of Craterispermum laurinum and Morinda lucida. BMC complementary and alternative medicine 14: 1.
- 14. Kirimuhuzya C, Waako P, Joloba M, Odyek O (2009) The anti-mycobacterial activity of Lantana camara a plant traditionally used to treat symptoms of tuberculosis in South-western Uganda. African health sciences 9: 40–45. pmid:20842241
- 15. Trees A, Graham S, Renz A, Bianco A, Tanya V (2000) Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments. Parasitology 120: 133–142.
- 16.
Bianco A, Ham P, ElSinnary K, Nelson G. Large-scale recovery of Onchocerca microfilariae from naturally infected cattle and horses; 1980. Royal soc tropical medicine manson house 26 Portland place, London, England W1N 4EY. pp. 109–110.
- 17. Wahl G, Achikwi MD, Mbah D, Dawa O, Renz A (1994) Bovine onchocerciasis in North-Cameroon. Veterinary parasitology 52: 297–311. pmid:8073613
- 18.
Cheesbrough (1987) Medical Laboratory manual for tropical countries. In: ELBS L, editor. 2 ed.
- 19. Bulman CA, Bidlow CM, Lustigman S, Cho-Ngwa F, Williams D, et al. (2015) Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis. PLoS Negl Trop Dis 9: e0003534. pmid:25700363
- 20.
(OECD) OfECoaD (2001) Guidelines for testing chemicals. Acute oral toxicity–Fixed dose procedure. Paris Mongragh.
- 21. Singh D, Singh P, Gupta A, Solanki S, Sharma E, et al. (2012) Qualitative estimation of the presence of bioactive compound in Centella asiatica: an important medicinal plant. International Journal of Life Science and Medical Science 2: 5–7.
- 22. Sanderson L, Bartlett A, Whitfield P (2002) In vitro and in vivo studies on the bioactivity of a ginger (Zingiber officinale) extract towards adult schistosomes and their egg production. Journal of helminthology 76: 241–247. pmid:12363378
- 23. Wang G-X, Zhou Z, Jiang D-X, Han J, Wang J-F, et al. (2010) In vivo anthelmintic activity of five alkaloids from Macleaya microcarpa (Maxim) Fedde against Dactylogyrus intermedius in Carassius auratus. Veterinary Parasitology 171: 305–313. pmid:20413222
- 24.
Tanya VN, Wandji S, Kamgno J, Achukwi DM, Enyong PA (2012) Recent advances in onchocerciasis research and implications for control.
- 25. Pass M, Seawright A, Lamberton J, Heath T (1979) Lantadene A toxicity in sheep. A model for cholestasis. Pathology 11: 89–94. pmid:431982
- 26. Begum S, Zehra SQ, Siddiqui BS, Fayyaz S, Ramzan M (2008) Pentacyclic triterpenoids from the aerial parts of Lantana camara and their nematocidal activity. Chemistry & biodiversity 5: 1856–1866.
- 27. Begum S, Ayub A, Qamar Zehra S, Shaheen Siddiqui B, Iqbal Choudhary M (2014) Leishmanicidal Triterpenes from Lantana camara. Chemistry & biodiversity 11: 709–718.